Rafael Bejar - Feb 5, 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
Sr VP & Chief Medical Officer
Signature
/s/ Rafael Bejar
Stock symbol
APTO
Transactions as of
Feb 5, 2024
Transactions value $
$0
Form type
4
Date filed
2/7/2024, 05:45 PM
Previous filing
Jan 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Employee Stock Option (Right to Buy) Award $0 +35K $0.00 35K Feb 5, 2024 Common Shares 35K $2.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the options vest on February 5, 2025, with the remaining options vesting as follows: 1/3 on February 5, 2026; 1/3 on February 5, 2027; and 1/3 on February 5, 2028.